Can Kashmiri saffron rice become a luxury category? LT Foods (NSE: LTFOODS) tests the idea with a numbered, expression-of-interest launch
LT Foods launches Daawat Saffron Basmati, a limited-edition luxury rice. What it means for brand strategy, KRBL competition, and LTFOODS investors. Read more.
Zydus (NSE: ZYDUSLIFE) unit Sentynl adds Korean progeria drug Progerinin to rare disease portfolio as Phase 2A data loom
Sentynl, Zydus Lifesciences' US subsidiary, licenses Progerinin from Korea's PRG S&T for progeria. Phase 2A data due H1 2026. Read the full analysis.
Kalpataru Projects (NSE: KPIL) FY26 order book races past Rs 22,000cr with fresh Rs 2,471cr wins
KPIL wins Rs 2,471 crore in orders covering underground metro rail, T&D, and B&F, lifting FY26 intake to Rs 22,000 crore. Read the full analyst briefing.
Challenger (ASX: CGF) cuts Pepper Money (ASX: PPM) offer to A$2.25 per share, calls it best and final
Challenger slashes its Pepper Money offer by 13.5% to A$2.25, citing market deterioration. What this means for shareholders and the deal. Read more.
ASX 200 top gainers: IperionX, Electro Optic Systems, and West African Resources lead the bounce as defence and gold catalysts converge
IperionX, Electro Optic Systems, and West African Resources top the ASX 200 gainers on 17 March. Here's what the moves mean for defence and gold investors.
Storms, TSA shutdown and spring break collide: 12,000 US flights hit in single day
More than 12,100 US flights were canceled or delayed on March 16, 2026, as major storms and a TSA staffing crisis from the government shutdown hit airports nationwide.
Cuba goes dark: Total grid collapse leaves 10 million without power amid US oil blockade
Cuba's national electric grid collapsed on 16 March 2026, leaving 10 million without power amid a US oil blockade and rare violent protests over blackouts and food shortages.
A trillion cubic feet under the Mediterranean? Eni’s Libya discovery may reshape Europe’s gas map
Eni discovers over 1 Tcf of gas offshore Libya near Bahr Essalam. Explore what the find means for European supply and Eni’s strategy. Read more.
Structure Therapeutics (Nasdaq: GPCR) posts 16% weight loss with oral GLP-1 drug aleniglipron, setting up Phase 3 push
Structure Therapeutics' aleniglipron hits 16% weight loss at 44 weeks in Phase 2, matching injectables. Read the full analysis before Phase 3 begins.
ArcelorMittal Kryvyi Rih (NYSE: MT) closes two more rolling mills as Russian strikes and EU carbon rules force Ukraine steel retreat
ArcelorMittal Kryvyi Rih closes two more rolling mills, risking 3,400 jobs. Read how Russian strikes and CBAM are dismantling Ukraine's steel industry.